Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell !!



Cannabis · Hemp · Hanf · Cannabinoids · THC · CBD · Medical · Medicinal ·

FDA · NHI · EMA · JMA · Patient · Patent · License · Audit · Report · SEC ·



MMJ = Medical Marijuana or CBD Hemp !



Medical Marijuana Inc. - Cannot Sell MMJ or CBD Products !!



Seems majority of its Investors mentally very

dependent, that normal commonsense market

considerations are not possible. Just Pumpers

fake oriented !

For example most of them like to believe, that

Registered MMJ or CBD Patients for Pain-Therapy

will pay annually about $ 8000.- to MJNA, when

they at any Pharmacy as even FDA Approved can

get for $ ZERO the principally much more expensive

CBD Sativex which is also killing Pain & Cancer as

it already worldwide does, but FDA Approved the

US Health Insurances completely paying for it !!



100% sure, 99% of Registered Patients are not

willing to pay annually $ 8000.- to MJNA as they

don’t need or not even have the money or with

that money better go for Holiday or do with it

something else in life important, instead of

paying for Companies such as MJNA !



Famous CBD Sativex is now at every US Pharmacy available !!!



MJNA at present has the most exposure and

because of this it gets most affected, but for

fairness its necessary to mention that any MJ

Company with desire to sell MMJ Products get

affected by its None FDA Approved Products

the US Health Insurances Therefore Not Pay !!

MJNA is additionally under SEC Investigations.



Small US MJ Companies not able to change

the Handling of the US Health Insurances !!



This for All Investors to think very well about !



PS : GW Pharmaceuticals the producer of its

patented Sativex, by its owner consortium is

related to Big Global Player Companies with

worldwide annual Revenue of about $ 168 Bn.

This only for knowing with what the small US

MJ Companies really dealing with and to see

the present situation as the beginning only !

For the additional Wellness- Products, there

will be coming Companies as Nestle, Unilever,

RedBull, Etc. also to keep well in mind !!

Its not that simple or easy as Pumpers Think !

Additionally New Fed. US MJ Laws to expect,

will KILL MJ THC Content Wellness Products !



MJNA’s “Cibaderm” is a Big Global Player NOVARTIS Brand ; Happy Lawsuits !!

According evidences MJNA Insisting on the Very Old Well Known Brand !



Additionally as known the SEC knocking at MJNA Doors !!

They Call That Inquiry When Doing Investigations ¨!!!



This With Compliments By On2_addict Presented.





As Investor if you may get or got harmed by any Short- Talk Blackmailing

or Misleading MB Members, just add www. to the Posts- Link to send and

File your Claims at ic3.gov CIA & FBI Branch - Internet Crimes, they help !



By The Company Abused, Mislead, Etc. ; Contact SEC Washington

To File Your Claims To Get Compensated !!

SEC Washington Hotline 202 551-6551 - Investors Protection

SEC Office Whistleblower at
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CPSC's Management Overhaul: Progress or Just Polishing?

Updated Category News Views 192

The Tangled Web of Bureaucracy Ah, the Consumer Product Safety Commission—CPSC for short. It's like the Secretariat of product safety, but often knee-deep in old problems. Over the years, hearing about their challenges is like flipping through a well-worn playbook. But now, the talk is all about a fresh page under Acting Chairman Peter A. Feldman. The watchdog in...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 40

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Philips’ Beauty Tech Trends Promise Intimacy by 2027

Updated Category News Views 66

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

Continue Reading
BETR Faces Shareholder Suit After Plummeting Stock

Updated Category News Views 29

Better Home & Finance Navigates Turbulent Waters Not every day the news comes up smelling of roses, and that's putting it lightly for Better Home & Finance, trading as NASDAQ: BETR. When you're talking about a splash that sends shockwaves, losing over 28% of your stock value on a single trading day is one whale of a splash indeed. The Numbers That Shook the Waters It's no...

Continue Reading
Beer B Que Music Festival: Hip-Hop, Dancehall & Brews

Updated Category News Views 31

A Melody and Brew-Infused South Florida Celebration Boy, if festivals were stocks, I'd have bought into the Beer B Que Music Festival years ago. This event, rolling into its seventh year, isn't just another line-up of artists—it feels like a genuine cultural reunion for folks in South Florida. You throw in some heavyweight names like Rick Ross and Kodak Black, plus the...

Continue Reading
Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Updated Category News Views 0

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

Continue Reading
Revamp Preschool Questions for Richer Conversations

Updated Category News Views 139

Preschoolers, those tiny agents of chaos, come home with stories that you'd need a magnifying glass to find. Ask 'em "How was school?" and you're met with blank stares or a one-liner. Tami Nix of Archway Academy has been at this game for over 40 years, and she's got a trick or six up her sleeve. Ditch the Generic: Get Specific Yep, those generic questions are about as...

Continue Reading
Commvault's Q2 Fiscal 2027 Shines Bright Amid Complexity

Updated Category News Views 0

Finding Stability in a Shifting Tech Landscape It doesn’t take a crystal ball to see that Commvault is navigating the whirlwind of tech innovation with some serious flair. Their latest quarterly earnings report for Q2 fiscal 2027 is a testament to the rising demand they're experiencing in a world where data protection and resilience are more than just buzzwords. Diving...

Continue Reading
Evaluating PT and OT Benefits: What’s Driving Outcomes?

Updated Category News Views 0

Shifting Gears: Rethinking PT and OT Benefits With an uptick in conversations around physical therapy (PT) and occupational therapy (OT) benefits, it's time for health plans and employers to step up their game. Let's face it: we're not just treating aches and pains anymore. We're dealing with the big picture here - helping folks get back to their daily grind effectively...

Continue Reading
CSQR Faces Scrutiny Over Cash Flow Discrepancies

Updated Category News Views 73

Dalrymple's Short Report Shakes Csquare's Core Csquare, Inc. (NYSE: CSQR) is reeling from a one-two punch: a damning short report by Dalrymple Finance and an 11.8% share tumble. The timing of this financial body blow, coinciding with Csquare's discordant cash flow claims, could mark the beginning of a long battle for investor trust. This ain't the first time the markets...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Update for DexCom Shareholders: Class Action Filed

Updated Category News Views 165

Class Action Lawsuit for DexCom, Inc. Investors Attention to all DexCom, Inc. investors: a significant class action lawsuit has been initiated for individuals facing substantial losses. The firm Bronstein, Gewirtz & Grossman, LLC has stepped forward, highlighting the opportunity for affected shareholders to take action. Understanding the Class Action This legal action is...

Continue Reading
Fly-E Group Faces Class Action Lawsuit Amid Investor Concerns

Updated Category News Views 180

Understanding the Fly-E Group Class Action Lawsuit Investors should be informed about the recent developments surrounding Fly-E Group, Inc. (NASDAQ: FLYE). A class action lawsuit has emerged, indicating a serious concern regarding the company’s financial and operational transparency. This opportunity is vital for investors who have experienced significant losses. Class...

Continue Reading
Torram Forms Alliance with Blockchain Founders Fund for DeFi

Updated Category News Views 150

Torram Collaborates with Blockchain Founders Fund Torram is thrilled to announce a significant partnership with Blockchain Founders Fund, a distinguished player in the world of blockchain investments. This alliance aims to foster financial technology innovation and maximize the potential of Bitcoin for institutional decentralized finance (DeFi). Unlocking Bitcoin's...

Continue Reading
RS Group Reports Major Advancements in ESG Commitment

Updated Category News Views 141

RS Group's ESG Report Reflects Commitment and Progress In an exciting update that marks a crucial point on its path to sustainability, RS Group's recent ESG report illustrates impressive advances tailored to ensure long-term value for all stakeholders. This latest report, part of their ESG action plan for 2030, allows a clear view of how they are integrating their...

Continue Reading
Investors Alert: Join the FCX Class Action Lawsuit Now

Updated Category News Views 85

Important Notice for Freeport-McMoRan Inc. Shareholders Freeport-McMoRan Inc. (NYSE: FCX) has come under scrutiny, prompting significant discussions among investors. If you've purchased shares in this company during the specified class period, it's essential to stay informed and take necessary action. Understanding the Allegations Against Freeport-McMoRan Inc. Recent...

Continue Reading